The global tetracyclines market is expected to witness significant expansion in the coming decade, growing from USD 32.82 billion in 2020 to an estimated USD 41.62 billion by 2032. This forecasted growth represents a Compound Annual Growth Rate (CAGR) of 2%, underpinned by supportive government policies and grants aimed at fostering pharmaceutical innovation. Tetracyclines, a …